Precision genomics for autoimmune diseases

At iCareX, we were approached by a client who had a vision to revolutionize the way autoimmune diseases were treated. They wanted to provide physicians and patients with personalized genomics reports for four different autoimmune diseases, including multiple sclerosis. As we began working on this project, we knew that the key to success was in understanding […]

Liferapy: An AI-Based Mobile App for Personalized Nutrition and Mental Health

Nutrition plays a crucial role in maintaining mental health and well-being. However, personalized nutrition plans that take into account individual preferences, biological profile, and mental health goals can be challenging to create and maintain. Here, we discuss some insights about Liferapy, an AI-based mobile app (we built) that generates personalized nutrition plans for users based on […]

iCareX 10 Insights on the Zepeto Metaverse: An Inside Look at the Next Generation Social Economy

The Zepeto Metaverse is a fascinating place, where users can create avatars and interact with others, taking part in challenges and simulations, and even marry one another. In this article, we’ll be presenting 10 unique insights we have got from researching and building on Zepeto, providing a view into its economy, influencer culture, fashion and design, and much more. Get ready to dive […]

Unleashing the Potential of the Metaverse: Insights from Our Pioneering Journey at iCareX

As a leading venture studio at the forefront of innovation, iCareX is always exploring new opportunities to harness the rapidly evolving metaverse landscape and support our clients’ growth. In our quest for excellence, we recently conducted extensive research into the most promising metaverse platforms, focusing on their monthly active user (MAU) base as a key metric of […]

iCareX, Venturing Into New Frontiers!

iCareX, a visionary venture studio, on a quest to disrupt the way innovation is delivered to the market. At iCareX, we bring together a dream team of experienced entrepreneurs, engineers, product specialists, domain experts and consultants who share a passion for creating impactful and innovative technologies and ventures. Our focus is on exploring new frontiers and pushing the boundaries of what is possible. We are always on the lookout for cutting-edge ideas across a wide range […]

The science-backed transcriptomic reports

The science-backed transcriptomic reports At iCareX, we were driven by a passion to improve the lives of those suffering from rheumatoid arthritis. That’s how the idea of iExpression, a platform we built to provide physicians and rheumatoid arthritis patients with science-backed transcriptomic reports, came about. As we began building iExpression, we knew that the key to […]

GENEVERSITY: il database con milioni di geni e cellule

Geneversity è il nuovo tool sviluppato dal team di iCareX, azienda biotecnologica impegnata nel promuovere lo sviluppo della medicina di precisione per le malattie autoimmuni attraverso l’intelligenza artificiale e i big data. L’idea è nata dalla necessità di creare un unico database contenente il maggior numero di informazioni possibili, utili per la ricerca dei geni […]

IDROSSICLOROCHINA: il farmaco antimalarico per l’Artrite Reumatoide

L’Artrite Reumatoide (AR) è una malattia infiammatoria cronica che colpisce oltre 3 milioni di persone in Europa [1]. Il segno distintivo di tale malattia è l’instaurarsi e il propagarsi di un processo infiammatorio e doloroso che colpisce le articolazioni periferiche fino a portarle alla deformità. Inoltre, circa il 40% dei pazienti va incontro a diverse […]

Sulfasalazina: la seconda scelta tra i farmaci di prima linea

Intorno agli anni ‘40, la sulfasalazina venne utilizzata per la prima volta nei confronti della Poliartrite Reumatica, un processo infiammatorio che provoca dolore e rigidità muscolare, cominciando dalle spalle, dal collo e dalle anche, per poi propagarsi al resto del corpo. Una condizione che, sotto certi punti di vista, assomiglia all’Artrite Reumatoide (AR), con la […]